top of page
external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus. 
Explore the latest updates from the life science industry.

Popular Content.

BIOPROCESSING

FUJIFILM Biotechnologies Launches UK’s Largest Single-Use Biomanufacturing Facility

£400 Million Expansion Strengthens the UK Life Sciences Sector, Enhances Biomanufacturing Capacity, and Supports NHS and Global Pharmaceutical Innovation.

 Featured Articles. 

7-format11240.jpg
BIOTECH

iXCells and Rosebud Team Up on Human Organoid Models

7-format11240.jpg
BIOTECH

First Human Egg 'Rejuvenation' Offers Hope for Older IVF Patients

7-format11240.jpg
PHARMA

Belite Bio Announces Landmark Phase 3 Success for Stargardt Disease

7-format11240.jpg
HEALTH

Kaia Health Joins Sword Health to Scale AI-Driven Musculoskeletal Care

7-format11240.jpg
HEALTH

Killing Mosquitoes With the Smell of Flowers

7-format11240.jpg
BIOTECH

Unexpected Protein Structure May Lead to New Cancer Treatments

7-format11240.jpg
HEALTH

Sanome Partners With NHS Trusts to Deploy AI-Powered Clinical Intelligence for Earlier Infection Detection

7-format11240.jpg
HEALTH

A Simple Pad Could Transform Cervical Cancer Screening

7-format11240.jpg
SUSTAINABILITY

Life on Mars - Science Fiction, or Real-Life Science?

 Latest News. 

11th February, 2026

01.

FUJIFILM Biotechnologies Launches UK’s Largest Single-Use Biomanufacturing Facility

£400 Million Expansion Strengthens the UK Life Sciences Sector, Enhances Biomanufacturing Capacity, and Supports NHS and Global Pharmaceutical Innovation.

8th February, 2026

02.

A Simple Pad Could Transform Cervical Cancer Screening

Population-based study shows menstrual blood testing matches clinic-based HPV detection, with far greater convenience.

7th February, 2026

03.

SynGenSys Launches Synthetic Promoter Library for Liver-Targeted Gene Therapies

New synthetic promoter tech promises sharper targeting for liver gene therapies

29th January, 2026

04.

Kaia Health Joins Sword Health to Scale AI-Driven Musculoskeletal Care

The acquisition brings together European digital therapeutics expertise and an AI-first care platform, signalling a new phase for evidence-based MSK care across public and private health systems.

Editor's Selects.

Weighing the Cost of Semaglutide

Women's Health Therapeutics Market Enters Transformative Growth Phase

Feeding The Future of Medicine

Biotechnology in Agriculture - Feeding the World’s Growing Population

Stay up-to-date. Connect with BioFocus on LinkedIn or subscribe to our mailing list.

bottom of page